138 related articles for article (PubMed ID: 30214245)
1. RGD-modified nanoliposomes containing quercetin for lung cancer targeted treatment.
Zhou X; Liu HY; Zhao H; Wang T
Onco Targets Ther; 2018; 11():5397-5405. PubMed ID: 30214245
[TBL] [Abstract][Full Text] [Related]
2. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy.
Wang WY; Cao YX; Zhou X; Wei B
Drug Des Devel Ther; 2019; 13():2205-2213. PubMed ID: 31308632
[No Abstract] [Full Text] [Related]
3. Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies.
Tang Z; Feng W; Yang Y; Wang Q
Drug Des Devel Ther; 2019; 13():3281-3290. PubMed ID: 31571830
[TBL] [Abstract][Full Text] [Related]
4. Liposomal quercetin: evaluating drug delivery in vitro and biodistribution in vivo.
Gang W; Jie WJ; Ping ZL; Ming du S; Ying LJ; Lei W; Fang Y
Expert Opin Drug Deliv; 2012 Jun; 9(6):599-613. PubMed ID: 22607534
[TBL] [Abstract][Full Text] [Related]
5. RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer.
Feng C; Li X; Dong C; Zhang X; Zhang X; Gao Y
Drug Des Devel Ther; 2015; 9():4613-20. PubMed ID: 26316700
[TBL] [Abstract][Full Text] [Related]
6. GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation.
Cheng L; Huang FZ; Cheng LF; Zhu YQ; Hu Q; Li L; Wei L; Chen DW
Int J Nanomedicine; 2014; 9():921-35. PubMed ID: 24611009
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells.
Hu J; Wang J; Wang G; Yao Z; Dang X
Int J Mol Med; 2016 Mar; 37(3):690-702. PubMed ID: 26782731
[TBL] [Abstract][Full Text] [Related]
8. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
9. RGD-modified pH-sensitive liposomes for docetaxel tumor targeting.
Chang M; Lu S; Zhang F; Zuo T; Guan Y; Wei T; Shao W; Lin G
Colloids Surf B Biointerfaces; 2015 May; 129():175-82. PubMed ID: 25851582
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance.
Bajelan E; Haeri A; Vali AM; Ostad SN; Dadashzadeh S
J Pharm Pharm Sci; 2012; 15(4):568-82. PubMed ID: 23106959
[TBL] [Abstract][Full Text] [Related]
11. A Novel Delivery System of Cyclovirobuxine D for Brain Targeting: Angiopep-Conjugated Polysorbate 80-Coated Liposomes via Intranasal Administration.
Wei H; Liu T; Jiang N; Zhou K; Yang K; Ning W; Yu Y
J Biomed Nanotechnol; 2018 Jul; 14(7):1252-1262. PubMed ID: 29944099
[TBL] [Abstract][Full Text] [Related]
12. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
[TBL] [Abstract][Full Text] [Related]
13. Sterically stabilized liposomes as a potent carrier for shikonin.
Kontogiannopoulos KN; Tsermentseli SK; Assimopoulou AN; Papageorgiou VP
J Liposome Res; 2014 Sep; 24(3):230-40. PubMed ID: 24597496
[TBL] [Abstract][Full Text] [Related]
14. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
15. Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation.
Jiang K; Shen M; Xu W
Int J Nanomedicine; 2018; 13():2561-2569. PubMed ID: 29731631
[TBL] [Abstract][Full Text] [Related]
16. Development of docetaxel liposome surface modified with CD133 aptamers for lung cancer targeting.
Ma J; Zhuang H; Zhuang Z; Lu Y; Xia R; Gan L; Wu Y
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1864-1871. PubMed ID: 29082764
[TBL] [Abstract][Full Text] [Related]
17. [Cellular toxicity and anti-tumor efficacy of iRGD modified doxorubixin loaded sterically stabilized liposomes].
Zhao B; Fan YC; Wang XQ; Dai WB; Zhang Q; Wang XL
Yao Xue Xue Bao; 2013 Mar; 48(3):417-22. PubMed ID: 23724658
[TBL] [Abstract][Full Text] [Related]
18. RGD-modified poly(D,L-lactic acid) nanoparticles enhance tumor targeting of oridonin.
Xu J; Zhao JH; Liu Y; Feng NP; Zhang YT
Int J Nanomedicine; 2012; 7():211-9. PubMed ID: 22275836
[TBL] [Abstract][Full Text] [Related]
19. Transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anticancer activity.
Chen Q; Liu J
Int J Nanomedicine; 2018; 13():6009-6018. PubMed ID: 30323588
[TBL] [Abstract][Full Text] [Related]
20. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
Nallamothu R; Wood GC; Kiani MF; Moore BM; Horton FP; Thoma LA
PDA J Pharm Sci Technol; 2006; 60(3):144-55. PubMed ID: 17089683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
